CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and COO gave up 13,954 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 5,904 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and COO gave up 23,185 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 1,214 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 28,337 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 38,451 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 16,344 shares (to pay taxes)
- 4 Grant or award Director acquired 7,915 shares (grant or award)
Page 3 of 38 · 752 filings